Physiologic Insulin Resensitization (PIR) is presented as a treatment modality for insulin resistance pathophysiology. The research explores its role in improving glycemic control and addressing various diabetes-related complications.
The publications on this page investigate the efficacy of Physiologic Insulin Resensitization in managing and potentially reversing diabetic neuropathy, diabetic retinopathy, and improving kidney function in chronic kidney disease. Studies also cover its impact on diabetic foot wounds.
The page features peer-reviewed publications that include retrospective studies, case series, and case studies. These studies evaluate the effects of Physiologic Insulin Resensitization on metrics like HbA1C, insulin sensitivity, and glycemic control.
Each publication title on this page is accompanied by a 'Click to Download' link. This allows users, such as healthcare professionals and researchers, to directly access and review the full text of the research papers.
